← Eichor
Condition: X Linked Hypophosphatemia Xlh Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: X Linked Hypophosphatemia Xlh

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Effective Dosing of Burosumab in XLH
Phase N/A · 1 location(s) · University of Nottingham · NCT07183579Registry for Patients With X-Linked Hypophosphatemia
Phase N/A · 118 location(s) · Kyowa Kirin Pharmaceutical Development Ltd · NCT03193476National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
Phase 1/Phase 2 · 9 location(s) · Kyowa Kirin Co., Ltd. · NCT06525636Phosphorus-31 Spectroscopy in Phosphate Diabetes
NA · 2 location(s) · Hospices Civils de Lyon · NCT06921720
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.